<DOC>
	<DOCNO>NCT01188759</DOCNO>
	<brief_summary>This study aim compare safety , tolerability , efficacy voriconazole anidulafungin combination versus voriconazole alone pediatric subject age 2 17 year invasive aspergillosis .</brief_summary>
	<brief_title>Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Neuroaspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Diagnosis proven , probable , possible invasive aspergillosis . Hematologic malignancy allogeneic hematopoetic stem cell transplant . Sarcoidosis , aspergilloma , allergic bronchopulmonary aspergillosis . Chronic invasive aspergillosis . Receipt antifungal treatment 96 hour . Severe liver dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Aspergillosis</keyword>
	<keyword>Combination Therapy</keyword>
	<keyword>Voriconazole</keyword>
	<keyword>Anidulafungin</keyword>
</DOC>